🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsClinical Trials & ResearchClinicalTrials.gov GLP-1 trial tracker — updated weekly Page 16

ClinicalTrials.gov GLP-1 trial tracker — updated weekly

TrialTracker_MD Mon, Feb 26, 2024 at 4:00 PM 255 replies 53,106 viewsPage 16 of 20
RetaRick_CA
VIP Member
2,012
9,876
Jan 2024
California
Feb 27, 2024 at 2:40 PM#76

100%. My provider said the same thing about ClinicalTrials.gov.

49 6SkepticalSean, Dr.CardioMD, EndoResFellow and 46 others
Reply Quote Save Share Report
Dr.RenalNash
VIP Member
1,234
7,890
Mar 2024
Nashville, TN
Feb 27, 2024 at 2:57 PM#77

Just wanted to say — for anyone reading this ClinicalTrials.gov thread who is feeling discouraged: it gets better. The first 6 weeks are the hardest. Hang in there. 💪

46 15pam_stl, wei_SG, cory_ATX and 43 others
Reply Quote Save Share Report
chris_chi24
Member
389
1,678
Sep 2024
Chicago, IL
Feb 27, 2024 at 3:14 PM#78

+1. This mirrors my journey exactly. The ClinicalTrials.gov discussion here is so valuable.

Last edited: Feb 27, 2024 at 6:14 PM
19 4MaxMetOK, MounjBrad, nick_newbie and 16 others
Reply Quote Save Share Report
JakeBK_lifts
Member
523
2,345
Jul 2024
Brooklyn, NY
Feb 27, 2024 at 3:31 PM#79

Just wanted to say — for anyone reading this ClinicalTrials.gov thread who is feeling discouraged: it gets better. The first few weeks are the hardest. Hang in there. 💪

50 24kate.chem, DataDave, Dr.GutHealth and 47 others
Reply Quote Save Share Report
rick_sfbay
Member
289
1,234
Jan 2025
San Francisco, CA
Feb 27, 2024 at 3:48 PM#80

Subscribing to this thread. ClinicalTrials.gov GLP-1 is exactly what I've been researching. 🙏

7 4Dr.BariatricHTX, LindaRN_retired, tommy_boulder and 4 others
Reply Quote Save Share Report

Similar Threads

FLOW trial: semaglutide renal outcomes — NEJM publication review14 replies
SELECT trial: semaglutide 2.4mg cardiovascular outcomes — 4yr data9 replies
TRIUMPH program (retatrutide) — Phase 3 trial design and endpoints13 replies
Orforglipron ATTAIN trials — oral non-peptide GLP-1 agonist8 replies
CagriSema (amylin + semaglutide) — REDEFINE Phase 3 results20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register